Lutz S.
- Country
- Germany
- Department
- na
Research Overview
- Phase III Randomized, Double‑Blind, Parallel‑Group Study of Elecoglipron Added to Dapagliflozin in Adults with Type 2 Diabetes Mellitus and Impaired Renal Function
- Efficacy and Safety Assessment of Finerenone and Empagliflozin Combination Versus Monotherapy in Chronic Kidney Disease with Type 2 Diabetes
- Efficacy and Safety Evaluation of Allogeneic Skin-Derived ABCB5-Positive Dermal Mesenchymal Stromal Cells in Therapy-Resistant Chronic Venous Ulcers
Data & Insights
Has run more than one trial at 23 of 156 partner sites.
Specializations
Wound Care & Healing
Specialized in treating chronic venous ulcers (CVU), particularly focusing on therapy-resistant cases that don't respond to conventional treatments. The investigator explores innovative approaches in wound healing through advanced therapeutic interventions.
- Non-healing venous leg ulcers
- Therapy-resistant wound management
- Topical wound treatments
Research encompasses novel cell-based therapeutic approaches for chronic wound healing.
Diabetic Complications
Investigates treatment solutions for patients with type 2 diabetes and associated complications, with particular emphasis on kidney-related conditions. The research focuses on combination therapy approaches to manage complex diabetic manifestations.
- Diabetic kidney disease management
- Therapeutic combinations
- Renal function monitoring
Evaluates innovative therapeutic combinations for improved patient outcomes in diabetic complications.
Nephrology
Specializes in the treatment of chronic kidney disease, particularly in the context of metabolic disorders. The investigator studies novel therapeutic approaches targeting kidney function markers and disease progression.
- Urinary biomarker analysis
- Kidney disease progression
- Metabolic disorder complications
Focuses on innovative treatment strategies for chronic kidney conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.